The oral form can be a reasonable option for patients who prefer not to self-inject, but clinical expectations should be calibrated accordingly
The current best practice is risk-based shared decision-making rather than universal discontinuation
These fake products, which may be circulating in the market without proper authorization, pose significant health risks due to the potential lack of active ingredients, incorrect dosages, or the presence of harmful substances
GLP-1 medications like Wegovy produce significantly more weight loss (approximately 15% of body weight) compared to Contrave (56%)
Body composition, metabolic rate, genetic factors, and concurrent medications all influence how your system responds to GLP-1 therapy
Fat-binding capacity Fat-binding capacity (FBC) was determined according to the method described by zdemir [40]